Thymus Neoplasms
Information
- Disease name
- Thymus Neoplasms
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01621568 | Active, not recruiting | Phase 2 | Sunitinib for Advanced Thymus Cancer Following Earlier Treatment | May 15, 2012 | July 31, 2024 |
| NCT00921739 | Completed | Phase 1 | Esophageal Sparing Intensity-modulated Radiation Therapy (IMRT) for Locally-Advanced Thoracic Malignancies | September 11, 2009 | November 2016 |
| NCT00591981 | Completed | Thoracic OncoGeriatric Assessment (TOGA) Trials | August 2007 | August 2012 | |
| NCT06189183 | Recruiting | N/A | Adjuvant Hypofractionation Radiotherapy for Thymic Epithelial Tumours After Complete Resection | November 11, 2023 | December 31, 2040 |
| NCT04822077 | Recruiting | N/A | Study on Proton Radiotherapy of Thymic Malignancies | April 18, 2018 | April 1, 2029 |
| NCT05918302 | Recruiting | Phase 3 | Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. | October 27, 2023 | July 2028 |
| NCT02859415 | Terminated | Phase 1/Phase 2 | Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases | August 8, 2019 | December 1, 2021 |
| NCT02364076 | Unknown status | Phase 2 | Pembrolizumab and Epacadostat in Patients With Thymic Carcinoma | March 2015 | December 2021 |
| NCT01610544 | Withdrawn | Phase 2 | 18F FLT Imaging Studies of Treatment Response for Lung Cancer and Thymoma | May 10, 2012 | December 10, 2012 |
- MeSH unique ID (MeSH (Medical Subject Headings))
- D013953